More about

Microrna

News
October 07, 2024
1 min read
Save

Nobel prize awarded for the discovery of microRNA and its role in gene regulation

Nobel prize awarded for the discovery of microRNA and its role in gene regulation

The 2024 Nobel Prize in Physiology or Medicine was jointly awarded to Victor R. Ambros, PhD, and Gary Ruvkun, PhD, for the discovery of microRNA and its role in gene regulation.

News
July 10, 2024
3 min read
Save

Some microRNA species increase odds for glycemic failure in youth-onset type 2 diabetes

Some microRNA species increase odds for glycemic failure in youth-onset type 2 diabetes

Circulating levels of some microRNA species may predict response to diabetes treatment and changes in beta-cell function among children and adolescents with type 2 diabetes, according to findings from the TODAY study.

Clinical Guidance
Genomics
Pathology and Sampling Techniques

Introduction to Liquid Biopsies

Edward S. Kim, MD, MBA, FACP, FASCO; Jennifer Benbow, PhD, CCRP

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News
December 02, 2022
3 min read
Save

Saliva analyses show potential in identifying predictive factors for infant food reactions

Saliva analyses show potential in identifying predictive factors for infant food reactions

LOUISVILLE, Ky. — Multi-omic analyses of saliva may improve understanding of what causes immune system-mediated food reactions, according to a presenter at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

News
January 09, 2020
2 min read
Save

Blood test may determine if kids are sleeping enough

Blood test may determine if kids are sleeping enough

A blood test could determine whether children are sleeping enough, according to a study published in Experimental Physiology.

News
September 09, 2019
2 min read
Save

MicroRNA blood test enhances results of low-dose CT screening for lung cancer

MicroRNA blood test enhances results of low-dose CT screening for lung cancer

BARCELONA — The use of a microRNA blood test in combination with low-dose CT screening reduced unnecessary repeat imaging and demonstrated value as a tool to assess an individuals’ lung cancer risk profile, according to results of the bioMILD trial presented during the presidential symposium of International Association for the Study of Lung Cancer World Conference on Lung Cancer.